A COMPARATIVE STUDY OF KAPAL BHATI AND MEDOHARA ARKA IN THE MANAGEMENT OF STHAULYA (OBESITY) by Garg, *Gunjan et al.
ISSN: 2322 - 0902 (P) 
ISSN: 2322 - 0910 (O) 
 IJAPR | April 2016 | Vol 4 | Issue 4  41 
International Journal of Ayurveda  





A COMPARATIVE STUDY OF KAPAL BHATI AND MEDOHARA ARKA IN THE MANAGEMENT OF STHAULYA 
(OBESITY) 
Gunjan Garg1*, Gopesh Mangal2, N.S. Chundawat3 
*1Associate Professor, Department of Swasthavritta, MJF Ayurveda College, Chomu, Jaipur, India.  
2Assistant Professor, Post Graduate Department of Panchkarma, National Institute of Ayurveda, Jaipur, India. 
3Former Professor & Head, PG Department of Swasthavritta & Yoga, National Institute of Ayurveda, Jaipur, India. 
ABSTRACT 
Obesity is a blessing of the Modern age of Machines and Materialism. The impact of modern civilization has 
absolutely changed our life styles. Most of the peoples are forced to live a sedentary life. Obesity is a type of 
disease, which invites many major & minor manifestations. Ayurveda has described one of such disorder as 
Sthaulya. The parallel in western medicine to this order is “Obesity. It is clinically prove that both Yoga and 
Ayurveda are mutually supportive and offer many ways to prevent and heal various disorders as well as 
cleanse and rejuvenate the body. Kapal Bhati is reliable to control the Sthaulya. Medohara Arka is known to 
exert several beneficial physiological effects including the anti-obesitic influence.  
Study Design: 90 patients, randomly divided into three groups with 30 patients in each group. In Group A, 
Kapal bhati was administered twice a day for 15 minutes in morning and evening on empty stomach for 45 
days. In Group B, Medohara arka was administered in 30 ml dose with Madhu anupana twice a day for 45 
days and in Group C, both Kapal Bhati and Medohara arka was administered as mentioned above.  
Results & Conclusion: Marked Improvement was not observed in any of the groups. Moderate Improvement 
was observed in 6.66 % patients in Group A and 3.33% in Group C. Mild Improvement was observed in 80% 
patients in Group C and 60% patients in Group A & 53.33% in Group B. No improvement was observed as 
36.66% in Group B, 33.33% in Group A and 16.66% in Group C. Thus, it can be concluded that the Kapal Bhati 
along with Medohara Arka is effective in the management of Sthaulya as it is safe, cost effective and free from 
any side effects. 
KEYWORDS: Kapal Bhati, Medohara Ark, Obesity, Sthaulya. 
INTRODUCTION 
 Obesity is one among the major diseases of 
modern era, increasing in prevalence. The Word Health 
report of W.H.O. listed Obesity under 10 top selected risks 
to the health. Obesity is a state of excess adipose tissue 
mass. Overweight refers to an excessive amount of body 
weight that includes muscle, bone, fat, and water[1] 
 Accumulation of fat over the limit led to 
ill/adverse effect in the body known as obesity. Body mass 
index (BMI) is an index of weight-for-height that is 
commonly used to classify overweight and obesity in 
adults. The World Health Organization (WHO) definition 
is: 1) A BMI greater than or equal to 25 is overweight and, 
2) A BMI greater than or equal to 30 is obesity. BMI 
provides useful population-level measure of overweight 
and obesity as it is the same for both sexes and for all ages 
of adults. However, it should be considered as rough 
guidance because it may not correspond to the same 
degree of fatness in different individuals.[2, 3] 
 Obesity is a major health threat. Overweight and 
obesity are linked to more deaths worldwide than 
underweight. For an example, 65% of the world's 
population live in countries where overweight and obesity 
kill more people than underweight (this includes all high-
income and most middle-income countries). Obesity is 
often associated with Dyslipidaemia which is a condition of 
abnormal levels of any of all lipids or lipoproteins in the 
blood. Obesity leads to other various complications like 
coronary artery disease, Diabetes Mellitus, Hypertension, 
Stroke, Gout, Infertility, Hypothyroidism, Psychological 
disorders, Gall stones and Cancer etc.[4] 
 The use of allopathic and pharmacological drugs 
has become a popular means to overcome excess weight 
gain [5]. While these drugs generally are effective, severe 
adverse toxicities may limit their overall usefulness [6, 7]. 
 In Ayurveda Obesity (Atishaulya) is described as 
medoroga”. Atisthaulya (obesity) is considered as one of 
the eight despicable conditions (Nindniya prakruties) 
according to the body constitution & obesity is one of them 
as described by Acharya Charaka [8]. undesirable person 
and he further stated that Sthaulya is a Santarpanjanya 
Vyadhi[9]. With help of classical therapy and Pathya-
Apathya concept of our Acharyas, we can give better 
results in Sthaulya[10] Sthaulya is counted as Kapha 
nanatmaj vyadhi in Charak samhita[11]. Sushrut Samhita 
also refers the Obesity (Sthaulya / medoroga) treatment in 
the Sutrasthan under the heading “Rasanimittamev 
Stholyam Karshyam Cha.[12] 
 It is clinically prove that both Yoga and Ayurveda 
are mutually supportive and offer many ways to prevent 
and heal various disorders as well as cleanse and 
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rejuvenate the body. Yoga have many simple, natural, 
effective remedies without toxic side effect and none 
expensive, need less care and attention and consume less 
time. Kapal Bhati is one of them. It is reliable to control the 
Sthaulya. Medohara Arka is known to exert several 
beneficial physiological effects including the anti-obesitic 
influence.  
Aims and Objectives 
 To assess the efficacy of kapal bhati in the 
management of Sthaulya. 
 To assess the efficacy of Medohara arka in the 
management of Sthaulya. 
 To compare the effect of Kapal Bhati and Medohara 
arka in the management of Sthaulya. 
MATERIALS AND METHODS 
Study type 
 Prospective, open randomized. Patients fulfilling 
criteria and attending OPD and IPD & Yoga Unit of Shri 
Dhanwantry Ayurvedic College & Dabur Dhanwantry 
Hospital, Chandigarh. Total 103 patients were registered 
for the current trial. Out of them, 10 cases dropped out 
from the study and study was completed in 93 cases. 
Further, 90 cases were selected for the present study. An 
informed written consent of all 103 patients was taken in 
language best understood by them 
Inclusion Criteria 
1. Patients aged between 16 to 60 years. 
2. Patients having clinical signs and symptoms of 
Sthaulya.  
3. Patients should not on any other medicine for 
Sthaulya. 
4. Patients willing to sign the consent form. 
Exclusion Criteria 
1. Patients below the age of 16 years and above 60 years.  
2. Patients with Hypothyroidism. 
3. Patients with long term Steroid treatment.  
4. Patients with severe Hypertension. 
5. Patients with evidence of Renal, Hepatic and Cardiac 
involvement.  
6. Patients with Diabetes mellitus. 
7. Pregnant women 
Diagnostic Criteria 
1.  It was mainly based on the specially prepared 
proforma, including all clinical signs and symptoms of the 
disease in which detailed history was taken and physical 
examination was done. Standard height–weight chart was 
also included (in all anthropometry). Moreover, the value 
of BMI, Circumferences and Skin Fold thickness were also 
used as diagnostic criteria.  
Investigations 
1.  Routine haematological, urine, stool examination 
were done to know the present status of patients as well as 
to exclude other pathological conditions. 
2. Relevant biochemical tests like S. Cholesterol, and S. 
triglyceride etc. were carried out before and after 
treatment. 
1) Group A – Kapal Bhati group: 
In this group Kapal bhati was administered twice a 
day, morning and evening respectively, on empty 
stomach. 
Time period: 15 min. 
Duration: 45 days  
2) Group B – Medohara arka group:[13] 
The components of Medohara Arka are –  
1. Gomutra Arka 1 liter 
2. Kesar (Crocus Sativus) 500 mg  
In this group Medohara ark was given orally twice a 
day, on empty stomach. 
Dose: 30 ml 
Duration: 45days  
Anupana: Madhoodaka 
3) Group C – Kapal Bhati with Medohara arka group : 
In this group, Kapal bhati was administered along with 
Medohara arka as mentioned above. 
Duration of the trial: 45 days 
Follow up: Patients will advise to visit for follow up 
after every fortnight for the duration of one month. 
Assessment Criteria  
Subjective Criteria 
1. Chala Sphika Udara Stana  
Absence of Chalatva 0 
Little visible movement (in the areas) after fast movement 1 
Little visible movement (in the areas) even after moderate movement 2 
Movement (in the areas) after mild movement 3 
Movement (in the areas) even after changing posture 4 
2. Alasya/Utsahahani  
No Alasya (doing work satisfactorily with proper vigor in time) 0 
Doing work satisfactory with initiation & late in time  1 
Doing work unsatisfactory with lot of mental pressure & late in time 2 
Not starting any work on his own responsibility and doing little work very slowly 3 
Does not take any initiation and not want to work even after pressure  4 
3. Kshudra shwasa 
Dyspnoea after heavy work (movement) but relieved soon and up to tolerance 0 
Dyspnoea after moderate work but relieved later and up to tolerance 1 
Dyspnoea after little work but relieved later and up to tolerance 2 
Dyspnoea after little work but relieved later and beyond tolerance  3 
Dyspnoea in resting condition  4 
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4. Daurbalya 
Can do routine exercise  0 
Can do moderate exercise without difficulty 1 
Can do only mild exercise 2 
Can do mild exercise with very difficulty 3 
Can not do even mild exercise 4 
5. Nidradhikya 
Normal sleep 6-7 hrs. per day 0 
Sleep up to 8 hours/day with anga gaurava 1 
Sleep up to 8 hours/day with anga gaurava and jrimbha 2 
Sleep up to 10 hours/day with tandra 3 
Sleep more than 10 hours/day with tandra and klama 4 
6. Swedadhikya (at normal temperature in normal condition) 
Sweating after heavy work and fast movement or in hot season 0 
Profuse sweating after moderate work and movement 1 
Sweating after little work and movement 2 
Profuse sweating after little work and movement 3 
Sweating even at rest or in cold season 4 
7. Daurgandhya  
Absence of bad smell 0 
Occasional bad smell from the body which removed after bathing 1 
Persistent bad smell limited to close areas difficult to suppress with deodorants 2 
Persistent bad smell felt from long distance and is not suppressed by deodorant 3 
Persistent bad smell felt from long distance even intolerable to the patient himself 4 
8. Ati Pipasa  
Normal thirst (1-2 liter intake of water) 0 
Up to 1 liter excess intake of water 1 
1 to 2 liter excess intake of water 2 
2 to 3 liter excess intake of water 3 
More than 3 liter excess intake of water 4 
9. Ati Kshudha 
Taking diet 2 times a day without any supplementary diet 0 
Taking diet 2 times a day with any supplementary diet 1 
Taking diet 3-4 times a day without any supplementary diet 2 
Taking diet 3-4 times a day with any supplementary diet 3 
Taking irregular or intermittent diet 4 
10. Anga gaurava (heaviness in body) 
No heaviness in body 0 
Feels heaviness in body but it does not hamper routine work 1 
Feels heaviness in body which hamper daily routine work 2 
Feels heaviness in body which hamper movement of the body 3 
Feels heaviness with flabbiness in all over body which cause distress to the person 4 
11. Alpa Vyavaya 
Unimpaired libido and sexual performance 0 
Decrease in libido but can perform sexual act 1 
Decrease in libido but can perform sexual act with difficulty 2 
Loss of libido and cannot perform sexual act 3 
12. Gatra Sada 
No fatigue 0 
Little fatigue in doing hard work 1 
Moderate fatigue in doing routine work 2 
Excessive fatigue in doing routine work 3 
Excessive fatigue even in doing little work 4 
Objective Criteria 
Cardinal measures  
 1. Weight 
 2. BMI 
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Circumference/ Skin fold thickness measurements 
 For the present study the girth measurements of 
certain regions using measuring tape/skin fold caliper 
before and after the treatment will also carried out. The 
girth measurement of following areas where generally the 
adiposity is found more was taken: 
1. Chest In normal expansion at the level of nipple. 
2. Waist At the level of umbilicus.  
3. Hip At the level of highest point of distension of 
buttock. 
4. Skin fold thickness of Biceps at mid level. 
5. Skin fold thickness of Triceps at mid level. 
6. Skin fold thickness of Sub-scapular  
7. Skin fold thickness of suprailiac  
Biochemical investigations 
S. Cholesterol, S. triglyceride, HDL and LDL 
Assessment Gradation 
The suitable scoring method for signs and symptoms were 
recorded in following patients. 
Not present/Absence of symptoms - 0 
Mild    - 1 
Moderate    - 2 
Severe    - 3 
Very severe    - 4 
Criteria for the Overall Effect of Therapy 
Overall the effect of therapy has been assessed as :  
Reduction in body weight  - 20% 
Reduction in BMI ratio - 20% 
Reduction in body circumference -10% 
Reduction in skin fold thickness - 10% 
Improvement in signs and symptoms  -40% 
OBSERVATIONS AND RESULTS 
 The maximum numbers of patients were in the 
age group of 18-30 yrs. i.e. 40%, Maximum patients i.e. 
76.66% were female, majority of patients i.e. 70% were 
Graduate /Post Graduate, Maximum patients i.e. 86.66% 
were performing sitting type or sedentary type of work, 
Maximum patients 81.11% were Married and 16.66% 
were bachelors, Majority of the patients i.e. 53.33% had 
Positive Family history,  
 In present series, patients were observed with 
Gatrasada and Anga gaurava in 94.44%, Chala Sphika 
Udara Stana and Daurbalya in 90% Alasya in 84.44%, 
Nidradhikya in 82.22%, Kshudra shwasa in 72.22%, 
Swedadhikya in 54.44%, Daurgandhya in 53.33%, 
Atikshudha in 50%, Alpa Vyavaya in 45.55% and Atipipasa 
was found in 32.22% of the patients.  
1. Chala Sphika Udara Stana 
Table 1: Showing pattern of clinical improvement in Chala Sphika Udara Stana in patient of all the three groups 
Group n 
Mean 
Relief % S.D. (±) S.E. (±) t p Results 
BT AT X 
A 27 2.92 1.62 1.33 45.56 .907 .174 7.634 0.001 H.S 
B 26 2.6 1.57 1.11 41.42 .802 .157 7.088 0.001 H.S 
C 28 3 1.53 1.46 48.80 .978 .184 7.918 0.001 H.S 
 2. Alasya/Utsahahani 




S.D. (±) S.E. (±) t p Results 
BT AT X 
A 29 2.89 2.03 0.89 30.95 0707 .131 6.82 0.001 H.S 
B 23 2.86 1.95 0.91 31.81 .676 .141 6.473 0.001 H.S 
C 24 3.125 1.875 1.25 40 .970 .198 6.312 0.001 H.S 
3. Kshudra shwasa 
Table 3: Showing pattern of clinical improvement in Kshudra shwasa in patient of all the three groups 
Group n 
Mean 
Relief % S.D. (±) S.E. (±) t p Results 
BT AT X 
A 22 2.95 2.04 0.95 32.30 .639 .136 7.005 0.001 H.S 
B 23 2.86 1.95 0.91 31.81 .676 .141 6.473 0.001 H.S 
C 20 3.1 1.9 1.2 38.70 .930 .208 5.764 0.001 H.S 
4. Daurbalya 








t p Results 
BT AT X 
A 26 2.92 1.96 1 34.21 .639 .125 7.977 0.001 H.S 
B 26 2.88 1.88 1 34.66 .685 .134 7.433 0.001 H.S 
C 29 3.1 1.9 1.2 38.70 .930 .208 5.764 0.001 H.S 
5. Nidradhikya 
Table 5: Showing pattern of clinical improvement in Nidradhikya in patient of all the three groups 
Group n 
Mean 
Relief % S.D. (±) S.E. (±) t p Results 
BT AT X 
A 22 2.50 0.33 2.17 86.80 0.407 0.167 12.99 0.001 H.S 
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B 25 2.12 0.75 1.37 64.62 0.521 0.185 7.405 0.001 H.S 
C 27 2.42 0.85 1.57 64.87 0.533 0.202 7.772 0.001 H.S 
 6. Swedadhikya (at normal temperature in normal condition) 
Table 6: Showing pattern of clinical improvement in Swedadhikya in patient of all the three groups 
Group n 
Mean 
Relief % S.D. (±) S.E. (±) t p Results 
BT AT X 
A 16 3 2 1.06 35.41 .852 .213 4.983 0.001 H.S 
B 15 2.73 1.66 1.06 39.02 .831 .214 4.970 0.001 H.S 
C 18 3.11 1.83 1.27 41.07 1.081 .254 5.011 0.001 H.S 
7. Daurgandhya 




Relief % S.D. (±) S.E. (±) t p Results 
BT AT X 
A 15 2.93 1.93 1.06 36.66 .894 .230 4.618 0.001 H.S 
B 16 2.81 1.68 1.12 40 .834 .208 5.390 0.001 H.S 
C 17 2.94 1.76 1.23 42 .926 .224 5.495 0.001 H.S 
 8. Ati Pipasa 
Table 8: Showing pattern of clinical improvement in Ati Pipasa in patient of all the three groups 






t p Results 
BT AT X 
A 10 1.80 1.00 0.80 44.44 0.578 0.183 4.371 0.01 S 
B 9 1.88 1.00 0.88 46.80 0.600 0.200 4.400 0.01 S 
C 10 1.70 0.70 1.00 58.82 0.816 0.258 3.875 0.01 S 
 9. Ati Kshudha 
Table 9: Showing pattern of clinical improvement in Ati Kshudha in patient of all the three groups 
Group n 
Mean 
Relief % S.D. (±) S.E. (±) t p Results 
BT AT X 
A 16 3 1.81 1.25 41.66 .965 .241 5.179 0.001 H.S 
B 13 2.76 1.76 1 36.11 .866 .240 4.163 0.01 S 
C 16 3.12 1.75 1.37 44 .904 .226 6.080 0.001 H.S 
10. Anga gaurava 
Table 10: Showing pattern of clinical improvement in Anga gaurava in patient of all the three groups 






t p Results 
BT AT X 
A 28 2.8928 1.5714 1.3571 46.91 .904 .171 7.913 0.001 H.S 
B 29 2.7586 1.6551 1.1034 40 .802 .148 7.405 0.001 H.S 
C 28 3 1.5 1.5 50 .916 .173 8.660 0.001 H.S 
11. Alpa Vyavaya 
Table 11: Showing pattern of clinical improvement in Alpa Vyavaya in patient of all the three groups 
Group n 
Mean 
Relief % S.D. (±) S.E. (±) t p Results 
BT AT X 
A 12 3 1.75 1.33 44.44 1.060 .306 4.354 0.01 S 
B 13 2.76 1.61 1.15 41.66 .833 .231 4.992 0.001 H.S 
C 16 3.12 1.62 1.5 48 .984 .246 6.093 0.01 S 
12. Gatra Sada 
Table 12: Showing pattern of clinical improvement in Gatra Sada in patient of all the three groups 
Group n 
Mean 
Relief % S.D. (±) S.E. (±) t p Results 
BT AT X 
A 27 2.92 1.70 1.25 43.03 .826 .159 7.917 0.001 H.S 
B 19 2.84 1.68 1.15 40.74 .941 .215 5.362 0.001 H.S 
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B: Anthropometric Profile 
1. Body Weight 
Table 13: Showing pattern of clinical improvement in Weight in patient of all the three groups 
Group n Mean Relief % S.D. (±) S.E. (±) t p Results 
BT AT X 
A 30 82.73 79.43 3.3 3.988 1.215 .221 14.871 0.001 H.S 
B 30 77.36 74.6 2.766 3.576 1.363 .248 11.112 0.001 H.S 
C 30 80.26 76.23 4.033 5.024 1.490 .272 14.819 0.001 H.S 
2. Body Mass Index (B.M.I) 
Table 14: Showing pattern of clinical improvement in Body Mass Index (B.M.I) in patient of all the three groups 
Group n Mean Relief % S.D. (±) S.E. (±) t p Results 
BT AT X 
A 30 34.93 33.3 1.633 4.675 .785 .143 11.38 0.001 H.S 
B 30 34.9 33.46 1.4333 4.106 .704 .128 11.139 0.001 H.S 
C 30 34.9 33.1 1.8 5.157 .618 .112 15.944 0.001 H.S 
 3. Chest Circumference 




S.D. (±) S.E. (±) t p Results 
BT AT X 
A 30 100.56 98.966 1.6 1.590 1.428 .260 6.133 0.001 H.S 
B 30 100.2 99 1.2 1.197 1.030 .188 6.377 0.001 H.S 
C 30 100.7 98.766 1.93 1.919 .944 .172 11.212 0.001 H.S 
4. Waist Circumference 




S.D. (±) S.E. (±) t p Results 
BT AT X 
A 30 107.8 103.33 4.466 4.413 1.306 .238 18.73 0.001 H.S 
B 30 107.53 103.73 3.8 3.533 1.423 .259 14.61 0.001 H.S 
C 30 107.8 102.86 4.933 4.576 .907 .165 29.785 0.001 H.S 
 5. Hip Circumference 




S.D. (±) S.E. (±) t p Results 
BT AT X 
A 30 109.93 106.03 3.9 3.547 1.398 .255 15.27 0.001 H.S 
B 30 107.53 103.73 3.8 3.533 1.423 .259 14.61 0.001 H.S 
C 30 107.8 102.86 4.93 4.576 .907 .165 29.785 0.001 H.S 
C: Biochemical Profile 
1. Serum Cholesterol 




S.D. (±) S.E. (±) t p Results 
BT AT X 
A 30 220.3 211.5 8.8 3.994 7.658 1.403 6.271 0.001 H.S 
B 30 220.8 211.63 9.2 4.166 7.888 1.440 6.387 0.001 H.S 
C 30 220.4 205.63 14.76 6.699 11.503 2.100 7.031 0.001 H.S 
 2. Serum triglycerides 
Table 19: Showing pattern of clinical improvement in Serum Triglycerides in patient of all the three groups 
 In the Kapal Bhati group, the results were highly 
significant and reduction in weight and B.M.I. ratio was 
3.98% and 4.6% respectively. Considering the effect of 
Kapal Bhati on body circumference, it provided highly 
significant relief with reduction of 4.41% in hip, 3.54% in 
waist, 1.59 % in chest circumference, whereas reduction in 
skin-fold thickness was obtained with statistically highly 
significant relief of 4.17% in biceps, 5.80% in triceps, 5.2% 
in sub-scapular and 6.22% in Suprailiac skin fold 
thickness. The effect of Kapal Bhati on biochemical 




S.D. (±) S.E. (±) t p Results 
BT AT X 
A 30 180.33 168.43 11.9 6.598 8.957 1.635 7.276 0.001 H.S 
B 30 181.3 168.8 12.5 6.894 8.463 1.545 8.089 0.001 H.S 
C 30 182.96 167.1 15.86 8.671 8.365 1.527 10.388 0.001 H.S 
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3.99 % in S. cholesterol, 6.59 % in S. triglyceride, and 
16.49% in serum LDL and 6.92% increase in serum HDL.  
 In the Medohara arka group, the results were 
highly significant and reduction was observed with 3.57% 
in weight and 4.1% in B.M.I. ratio. Considering the effect of 
Medohara arka on body circumference, it provided highly 
significant relief with 3.53% in hip, 4.57% in waist, 1.19 % 
in chest circumference, whereas reduction in skin-fold 
thickness were obtained with statistically highly 
significant relief of 3.47% in biceps, 4.25% in triceps, 4.5% 
in sub-scapular and 7.36% in Suprailiac skin fold 
thickness. The effect of Medohara arka on biochemical 
parameters provided significant reduction with relief of 
4.16 % in S. cholesterol, 6.89 % in S. triglyceride, 16.74% 
decrease in serum LDL and 6.58% increase in serum HDL.  
 In kapal Bhati with Medohara arka group, the 
results were highly significant and reduction was observed 
with 5.02% relief in weight and 5.15% relief in B.M.I. ratio. 
Considering the effect of Kapal Bhati with Medohara arka 
group on body circumference, it provided highly 
significant relief with 4.57% in hip, 4.57% in waist, 1.91 % 
in chest circumference, whereas reduction in skin-fold 
thickness were obtained with statistically highly 
significant relief of 5.28% in biceps, 6.5% in triceps, 6.9% 
in sub-scapular and 8.47% in Suprailiac skin fold 
thickness. The effect of kapal Bhati with Medohara arka on 
biochemical parameters provided significant reduction 
with relief of 6.69% in S. cholesterol, 8.67% in S. 
triglyceride, 19.40% decrease in serum LDL and 7.49% 
increase in serum HDL.  
DISCUSSION 
 Obesity is considered to be a disorder of energy 
balance, occurring when energy expenditure is no longer 
in equilibrium with daily energy intake, so as to ensure 
body weight homeostasis. Although the etiology of obesity 
is complex, dietary factors, particularly the consumption of 
an atherogenic diet, is considered a risk factor for its 
development.[14]It is well known that obesity is associated 
with increased adipose tissues accumulation in the body. 
In Ayurveda the role of Agni (digestive fire) is quite 
relevant to life and responsible factor for maintenance of 
health, digestion and metabolism from gross to subtle 
level. Diminished function of Agni is responsible for 
formation of Ama, i.e. an unwanted metabolic waste 
product at respective level. Ama has tendency to block the 
micro-channels (Srotorodha), i.e. Medovaha srotasa, and 
increases Ama Meda resulting to obesity.[15] 
Effect of Medohara arka on Sthaulya may be as follows: 
Dosha: Kapha dosha takes place in the pathogenesis of 
Sthaulya. Medohara ark is having Kaphahara action by 
virtue of its Ushna virya, thus it encounters Kapha dosha. 
Kaphahara action is also achieved by its dominance of 
Katu rasa and laghu-ruksha guna. 
Dushya: Meda is the chief culprits in Sthaulya. Medoahara 
arka performs Medo-shoshana action due to Katu rasa and 
dominance of Ruksha guna. Ushna virya also helps in Meda 
vilayana action.  
Agni and Ama Dosha: Medohara arka have Deepana, 
Pachana and Lekhana properties by virtue of Katu rasa 
and Ushna virya. Thus, it increases Agni and helps in 
Amapachana thereby, alleviates Aparipakwa and Ama 
dhatu. Katu rasa and Ushna virya also encounters 
Dhatwagnimandya and potentiates the weakened 
Dhatwagni. 
Srotas: Due to Katu rasa, Medohara arka dilated all the 
involved channels i.e.”Srotansi vivrunoti action”. Katu rasa 
and Ushna virya checks over Medovaha and Mamsavaha 
srotodushti.  
Effect of Kapal Bhati on Sthaulya may be as follows 
 Kapha and Meda are chief culprits in Sthaulya. 
Kapalbhati eliminates vitiated Kapha Dosha and reduces 
Meda. Mandagni, Ama-dosha and Medodhatwagni-mandya 
plays an important role in pathogenesis of Sthaulya. 
Kapalbhati corrects the Agni, which pacifies Ama Dosha 
and encounters Dhatwagni-mandya & potentiates the 
weakened Dhatwagni including Medodhatwagni.  
 Alpa Vyavaya and Ati Pipasa in Kapal Bhati Group, 
Ati Pipasa and Ati Kshudha in Medohara Arka Group, Alpa 
Vyavaya in Kapal bhati and Medohara arka Group showed 
statistically significant (p< 0.01) with mild relief and rest 
all symptoms showed highly significant result in all 
groups.  
 Whereas it was observed that in Kapal Bhati and 
Medohara arka group, percentage relief in all signs and 
symptoms was more achieved compared to Kapal bhati 
group and Medohara arka group. 
 Kapal Bhati with Medohara arka Group showed 
maximum percentage relief in all subjective as well as 
objective parameters except in nidradhikya. This is the 
only symptom in which Kapal Bhati showed maximum 
percentage relief. 
 Medohara arka group showed higher percentage relief 
as compare to Kapal Bhati Group in Suprailiac skin 
fold thickness, S. cholesterol, S. triglyceride and serum 
LDL.  
 Kapal Bhati Group showed higher percentage relief as 
compare to Medohara arka group in all 
Anthropometric profile except in Suprailiac skin fold 
thickness and serum HDL. 
CONCLUSION 
 Sthaulya is a predominant metabolic disorder, which is 
described by Charaka in Ashtaunindita Purusha. 
Sedentary life, lack of exercise, faulty food habits, and 
urbanization precipitate the disease. Genetic 
predisposition, Kapha predominant Prakriti increases 
the prevalence of Sthaulya. 
 In Kapal Bhati and Medohara arka group, percentage 
relief in all signs and symptoms was more achieved 
compared to Kapal Bhati group and Medohara arka 
group.  
 Kapal Bhati with Medohara arka Group showed 
maximum percentage relief in all subjective as well as 
objective parameters except in nidradhikya. This is the 
only symptom in which Kapal Bhati showed maximum 
percentage relief. 
 Medohara arka group showed higher percentage relief 
as compare to Kapal Bhati Group in Suprailiac skin 
fold thickness, S. cholesterol, S. triglyceride and serum 
LDL.  
 Kapal Bhati Group showed higer percentage relief as 
compare to Medohara arka group in all 
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Anthropometric profile except in Suprailiac skin fold 
thickness and serum HDL. 
 It can be said that Medohara arka is more effective to 
control S. triglyceride, S. cholesterol and L.D.L due to 
its Karshana, Lekhana etc. properties. 
 Overall comparison of all the parameter showed that 
effect of Kapal Bhati with Medohara arka group was 
better on reduction of Weight, B.M.I., Skin fold 
thickness, Body circumference, lipids and Signs and 
Symptoms.  
 On the completion of follow up study, it was found that 
weight was not regained in 14 patients out of 65. 
Maximum recurrence was noted in Medohara group. 
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